Yesterday, Senate Republican leaders released their version of health-care legislation. The bill is best understood as a GOP amendment to the Affordable Care Act. In 2009, if the Republicans had attempted to modify rather than defeat the ACA, this is the kind of amendment they might have offered.
The Payment Reform Landscape: Is The Debate Over Retrospective Versus Prospective Bundled Payments A Distraction?
Setting a prospective target budget, instituting reasonable downside financial risk, and tying final payment amounts to performance on a set of outcome measures all provide powerful incentives to manage patients well while adhering to a budget.
On June 22, 2017, Senate Majority Leader Mitch McConnell (R-KY) released the Senate GOP’s version of Affordable Care Act repeal, the Better Care Reconciliation Act of 2017. The Senate bill is in many respects quite different from the House’s American Health Care Act.
It is clear that health equity means different things to different people. While it’s not imperative that everyone define it exactly the same way, a common understanding of the core elements of health equity is essential.
A new study finds that black patients in traditional Medicare were 33 percent more likely than white patients to be readmitted to the hospital within thirty days.
June 21, 2017 | Elsewhere@ Health Affairs
Deploying The Cascade Of Care Framework To Address The Opioid Epidemic Means Taking A Closer Look At Quality Measures
The Cascade of Care is a useful framework to address the opioid epidemic, however to make this vision a reality, we need to develop the framework’s quality measures.
The nonprofit Breast Treatment Task Force, a partnership-based payment and delivery system model, facilitates screenings, diagnostic follow-ups, and treatments for a variety of people in New York City who lack insurance coverage. Donations from health care providers, foundations, and others are...
On Tuesday, June 13, the Senate HELP Committee held the first of three planned hearings on high drug prices. One of the most important points to come out of the hearing was that there is bipartisan concern about high drug prices, even if there is as yet little agreement on what to do about them.
I believe one way to “preserve” Medicare is to stop paying for unnecessary care: Instead, we should Choose Wisely.
On June 12, the Supreme Court ruled that biosimilar companies will generally be able to launch their product as soon as the data exclusivity on the innovative product expires. In simple terms, this translates to cheaper medicines sooner. On a second issue, the outcome was more complex.